RELMADA THERAPEUTICS, INC. Common Stock, Capital Shares Reserved for Future Issuance
RELMADA THERAPEUTICS, INC. (RLMD) had Common Stock, Capital Shares Reserved for Future Issuance of 597.37 thousand shares as of 2023-09-30, per its 10-Q filed 2023-11-08.
Discontinued › Notes › Equity › Stockholders' Equity Note › Class of Stock Disclosures › Common Stock, Number of Shares, Par Value and Other Disclosure
us-gaap:CommonStockCapitalSharesReservedForFutureIssuance · last filed 2023-11-08
- 2023-09-30: Common Stock, Capital Shares Reserved for Future Issuance 597.37K shares.
- 2023-05-31: Common Stock, Capital Shares Reserved for Future Issuance 2.50M shares.
- 2022-05-31: Common Stock, Capital Shares Reserved for Future Issuance 3.90M shares.
| Period end | Common Stock, Capital Shares Reserved for Future Issuance |
|---|---|
| 2023-09-30 | 597.37K shares 10-Q · filed 2023-11-08 |
| 2023-05-31 | 2.50M shares 10-Q · filed 2023-11-08 |
| 2022-05-31 | 3.90M shares 10-Q · filed 2023-11-08 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Opus Genetics, Inc. (IRD) | United States | $0.406B | -3.16 |
| Arcturus Therapeutics Holdings Inc. (ARCT) | $0.402B | -2.05 | |
| GALECTIN THERAPEUTICS INC (GALT) | United States | $0.399B | -11.06 |
| ARS Pharmaceuticals, Inc. (SPRY) | United States | $0.414B | -3.70 |
| Atea Pharmaceuticals, Inc. (AVIR) | United States | $0.414B | -2.26 |
| Turn Therapeutics Inc. (TTRX) | United States | $0.397B | -25.68 |
| DiaMedica Therapeutics Inc. (DMAC) | United States | $0.423B | -10.11 |
| PROTHENA CORP PUBLIC LTD CO (PRTA) | Ireland | $0.428B | -11.53 |
| Rezolute, Inc. (RZLT) | United States | $0.382B | -6.45 |
| CYPHERPUNK TECHNOLOGIES INC. (CYPH) | United States | $0.438B | -75.63 |